GlassScriptPhysician profile
Francisco Pernas
NPI 1932309754
$70,030.89
in general payments reported to CMS, 2019-2025
25 companies · $20K in 2025
The $20K reported for 2025 was more than what 98% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $5,417 · 2021: $7,900 · 2022: $16K · 2023: $3,248 · 2024: $6,781 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25K · Food and Beverage: $4,213 · Travel and Lodging: $460 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,920.00 |
| Food and Beverage | $4,212.66 |
| Travel and Lodging | $459.83 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $63,520.36 | 2019-2025 | |
| Intersect Ent, INC. | $1,113.68 | 2019-2021 | |
| Genzyme Corporation | $911.15 | 2019-2025 | |
| Stryker Corporation | $889.48 | 2020-2024 | Scopis Ent |
| Glaxosmithkline, LLC. | $861.29 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $747.98 | 2019-2025 | Dupixent |
| Aerin Medical INC. | $490.78 | 2019-2024 | |
| Smith+Nephew, INC. | $342.90 | 2019-2025 | Grafix Pl, Stravix |
| Medtronic, INC. | $329.51 | 2021-2025 | Propel, Stealthstation S8 Platform, Nuvent |
| Acclarent, INC | $253.17 | 2019-2023 | Relieva Spinplus |
| Hikma Pharmaceuticals USA | $99.06 | 2023-2025 | Ryaltris |
| Integra Lifesciences Corporation | $96.83 | 2020-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Mylan Pharmaceuticals INC. | $64.12 | 2019-2020 | |
| Kaleo, INC. | $47.79 | 2019-2022 | |
| Inspire Medical Systems, INC. | $46.50 | 2023 | Inspire |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $35.58 | 2019-2021 | |
| Amgen INC. | $34.00 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $23.51 | 2025 | Neffy |
| Medtronic USA, INC. | $22.76 | 2020 | |
| Greer Laboratories, INC. | $19.77 | 2019 | |
| Checkpoint Surgical, INC | $19.00 | 2023 | Checkpoint Stimulators |
| Novartis Pharmaceuticals Corporation | $18.24 | 2019 | |
| Aroa Biosurgery Incorporated | $16.32 | 2024 | |
| Olympus America INC. | $14.75 | 2020 | |
| Cook Medical LLC | $12.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francisco Pernas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.